Drug intelligence / Profile preview

scutellaria baicalensis

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Scutellaria baicalensis is a perennial flowering plant native to East Asia and widely used in traditional Chinese medicine (TCM) for over 2,000 years. The dried root—known as Huang Qin—is a key ingredient in many TCM formulas for treating conditions such as hepatitis, respiratory infections, inflammation, cancer, liver disease, anxiety, and insomnia[1][5][6][9]. Its pharmacological effects are attributed mainly to its bioactive flavonoids (baicalin, wogonin, and baicalein), which exhibit anti-inflammatory, antioxidant, antibacterial/antiviral activity; neuroprotective effects; anticancer properties via apoptosis induction and cell cycle arrest; modulation of neurotransmitters; immune enhancement; and potential hepatoprotective actions[1][3][6][7][8]. Mechanistically these compounds act on multiple molecular targets including GABA receptors (modulating CNS activity), solute carrier transporters (affecting drug absorption/metabolism), heat shock protein 90 (HSP90), JUN/RELA/AKT1 signaling pathways in cancer cells[1][7]. Modern research supports its multi-targeted action profile but robust clinical evidence remains limited. It is available as herbal teas/extracts/capsules/powders.

Brand names
Huang Qin
Other names
Chinese skullcapScutellaria baicalensis GeorgiHuang-QinBaikal skullcap
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)BZD site (GABA-A receptor benzodiazepine site)VEGFA (Vascular endothelial growth factor A)GABA-B (Gamma-aminobutyric acid receptor type B)HSP90AB1 (Heat shock protein HSP 90-beta)JUN (Transcription factor Jun)RELA (Nuclear Factor Kappa B Subunit p65)CCL21 (Chemokine (C-C motif) ligand 21)

Beyond the preview

Go deeper on scutellaria baicalensis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on scutellaria baicalensis.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call